Elevated DHEA-Sulfate Levels: Causes and Clinical Approach
Elevated DHEA-S levels most commonly indicate adrenal hyperandrogenism, with the primary causes being adrenal neoplasms, congenital adrenal hyperplasia, PCOS (in 20-30% of cases), and less commonly prolactinomas or ovarian tumors.
Primary Causes to Evaluate
Adrenal Sources (Most Common)
- Adrenal neoplasms: DHEA-S is traditionally considered a marker of adrenal androgen production, and markedly elevated levels (>700 mcg/dL) should prompt imaging with CT to exclude adrenal tumors 1
- Congenital adrenal hyperplasia: Particularly 21-hydroxylase deficiency (classic or non-classic forms). Consider this in high-risk ethnic groups (Ashkenazi Jews 1:27, Hispanics 1:40, Slavics 1:50) and measure early morning follicular phase 17-hydroxyprogesterone 1
- Cushing's syndrome: Evaluate if clinical features suggest hypercortisolism 1
Ovarian Sources
- PCOS: Approximately 20-30% of PCOS patients demonstrate excess adrenal precursor androgen production with elevated DHEA-S 2. These women show generalized exaggeration in adrenal steroidogenesis in response to ACTH stimulation
- Ovarian sex cord-stromal tumors: Although rare, ovarian neoplasms can produce markedly elevated DHEA-S despite the traditional teaching that ovaries lack sulfotransferase. This has been documented in steroid cell tumors 3
Endocrine Disorders
- Prolactinomas: An underrecognized association exists between hyperprolactinemia and elevated DHEA-S. Both prolactin and DHEA-S normalize with cabergoline therapy, suggesting a direct mechanistic link 4
- Thyroid dysfunction and acromegaly: Evaluate if clinical features are present 1
Other Associations
- Arterial hypertension: High DHEA-S levels were found in 26% of patients with hypertension in one cohort 5
- Obesity: Elevated DHEA-S correlated with higher BMI and weight 5
- Valproic acid: The only anticonvulsant that raises androgen levels 1
Diagnostic Algorithm
When DHEA-S is elevated, proceed systematically:
- Determine the degree of elevation: Markedly elevated levels (>700 mcg/dL) strongly suggest adrenal or ovarian neoplasm
- Measure early morning total testosterone as the initial androgen assessment 1
- Obtain pelvic ultrasonography to detect ovarian neoplasms or polycystic ovaries 1
- Check prolactin level to exclude the underrecognized prolactinoma-DHEA-S association 4
- Measure early morning 17-hydroxyprogesterone in high-risk patients for congenital adrenal hyperplasia 1
- Perform adrenal CT imaging if DHEA-S is markedly elevated or if adrenal tumor is suspected 1
- Assess for Cushing's syndrome if clinical features are present 1
Critical Pitfalls
Do not assume elevated DHEA-S is exclusively adrenal in origin. While DHEA-S is traditionally considered an adrenal marker, ovarian tumors can produce markedly elevated levels despite the presumed absence of sulfotransferase in ovarian tissue 3. This phenomenon remains mechanistically unclear but has important clinical implications for localization.
Consider prolactinoma even in the absence of typical symptoms. The association between hyperprolactinemia and elevated DHEA-S is underrecognized, and both normalize with dopamine agonist therapy 4. This should be considered after excluding more common etiologies.
In PCOS patients with elevated DHEA-S, the excess represents a generalized inherited exaggeration in adrenal steroidogenesis rather than a discrete enzyme defect 2. Extra-adrenal factors (obesity, insulin, ovarian secretions) play limited roles in this APA excess.